You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart

Article: P2.16 Activation of invariant natural killer T cells reduces angiogenesis in the 5T33 multiple myeloma model

€2.42

SKU: product-article-19543 Category: General

Description
Reviews (0)

Description

P2.16 Activation of invariant natural killer T cells reduces angiogenesis in the 5T33 multiple myeloma model

Reviews

There are no reviews yet.

Be the first to review “Article: P2.16 Activation of invariant natural killer T cells reduces angiogenesis in the 5T33 multiple myeloma model”

Top

Article: P2.16 Activation of invariant natural killer T cells reduces angiogenesis in the 5T33 multiple myeloma model

Description

Reviews

Related products

Article: Highlights in squamous cell carcinoma of the head and neck

Article: Highlights in gynaecological cancers

Article: Highlights in digestive oncology

Article: Highlights in melanoma